BioCentury
ARTICLE | Clinical News

Marqibo vincristine regulatory update

November 8, 2004 8:00 AM UTC

The partners submitted an NDS to Health Canada for Marqibo as a single-agent for patients with relapsed aggressive non-Hodgkin's lymphoma (NHL) previously treated with at least 2 combination chemother...